Sun Pharmaceutical's Unloxcyt is recommended in cancer care guidelines as a significant treatment option for locally advanced ...
The product is a generic version of Bristol-Myers Squibb’s Paraplatin and will be manufactured by Chennai-based contract ...
AstraZeneca and Amgen announce a breakthrough in asthma treatment with Tezspire, showing 69% remission in patients with ...
AstraZeneca collaborates with Oracle to leverage AI and real-world data for enhanced patient recruitment and safety ...
The US FDA has issued new guidance on the development and labeling of apps used alongside prescription drugs, aiming to ...
China's Hansoh Pharmaceutical has partnered with Roche in a groundbreaking licensing deal worth over $15 billion, focusing on ...
Metis TechBio collaborates with Eli Lilly to develop innovative tissue-specific drug delivery technologies worth up to $1.1 ...
EyePoint Pharmaceuticals announces a drastic workforce reduction amidst ongoing struggles with its experimental drug, Duravyu ...
Merck KGaA announced its acquisition of Silence Therapeutics for $1.3 billion, enhancing its gene silencing strategies and ...
Disc Medicine's late-stage trial success reveals promising results for its experimental sun-allergy pill, bitopertin, ...
Sun Pharmaceutical Industries is set to raise 100 billion rupees ($1.05 billion) through five-year bonds, aimed at ...
The approved ANDA is therapeutically equivalent to Sandoz’s Ciprodex Otic Suspension, which has an estimated market of $110 million, according to IQVIA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results